IPO
IPO
Best Performers
Forthcoming Issues
Closed Issues
New Listings
Current Issues
IPO Performance
IPO News
IPO Analysis
Basis of Allotment
Draft Prospectus
  HOME  >  IPO  >   IPO SNAPSHOT
IPO Snapshot    
Nureca Ltd.
Issue Open Date 15-Feb-21  
Issue Closing Date 17-Feb-21  
Application Money 100  
Allotment Money  
Price Band 396 - 400  
Minimium Application No. 35  
Issue Size (Shares) 2500175  
Market Lot 1.00  
Objective
1. Funding incremental working capital requirements of our Company; and2. General corporate purposes.
Category No. of Shares No. of Shares Subscription Ratio
  Offered / Reserved Bid For  
Non-Institutional Investors   375000   5435605   14.49  
Qualified Institutional Buyers   750000   2147110   2.86  
Retail Individual Investors   250000   23090970   92.36  
Business Description
Nureca is a B2C company engaged in the business of home healthcare and wellness products, which offers quality, durability, functionality, usability and innovative designs. The company enables its customers with tools to help them monitor chronic ailments and
more...
Promoter's Holding
Total Share Capital   6999993  
Offered to Public   2500175  
Promoter's Holding (Pre-Issue)   93.33  
Promoter's Holding (Post-Issue)   70  
Address
Office No. 101
1st Floor
Udyog Bhavan Sonawala Lane
Goregaon East
Mumbai ,
Maharashtra ,
400063
Phone: 0172-5292900
Email: cs@nureca.com
Website: www.nureca.com
Registrar
Link Intime India Pvt Ltd.
C 101
247 Park
LBS Marg
Vikhroli (West)
Mumbai
Listed at
BSE, NSE
Lead Manager
ITI Capital Ltd.
Promoters
Saurabh Goyal
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Awareness & Information | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.